Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Epicept Investors Still Waiting on News of a Partner
- VFC submits: Shares of Epicept EPCT have logged quite the volatile week of trading after a price spike carried shares to near the $1 mark before immediately retreating to the eighty cent level.A press release was issued on Thursday by the company highlighting some recent positive recognition for Ceplene,...
- External links 2009-09-06
- Keryx Pharmaceuticals: Time to Buy Back In
- VFC submits: When shares of Keryx Biopharmaceuticals KERX spiked to over three dollars on Tuesday after the company issued a press release regarding the continued "impressive" efficacy of its treatment for Advanced Metastatic Renal Cell Carcinoma, Perifosine, I stated that it was a good time to take some profits...
- External links 2009-10-04
- Access Pharma's Prospects Look Good Even Without a Buyout
- VFC submits: An email from 'Marty' regarding Access Pharmaceuticals (ACCP.OB):What's your take on Access Pharma?...I'm hearing lots of takeover rumors but that's not enough to warrant a strong position. What are its prospects as a stand-alone and what are your thoughts about a possible buy out? by VFC's Stock...
- External links 2009-10-04
- Cel-Sci May Be in for a Bumpy Ride This Week
- VFC submits: It looks like the writing staff at BioMedReports.com, most notably M. E. Garza, must be getting under Adam Feuerstein's skin because he's decided to enact a personal vendetta with the website. The thing is, it makes Adam and his puppetmasters at the The Street.com looks pretty bad...
- External links 2009-10-04
- Investors Should Ignore the Hoopla Around Cel Sci
- VFC submits: Shares of Cel Sci CVM traded down during pre-market trading on Tuesday after The Street.com published yet another article bashing the company and the potential of its pipeline. Undoubtedly some shareholders are going to be shaken out of the stock by the antics of Feuerstein, but I...
- External links 2009-10-07
- Time to Gain a Foothold in Transdel Pharma
- VFC submits: Shares of Transdel Pharmaceuticals (TDLP.OB) traded up to as high as four dollars during early trading on Tuesday after the company announced positive Phase III trial results for its lead topical pain drug Ketotransdel. The trial, according to the press release, "evaluated the efficacy and safety of...
- External links 2009-10-07
- BioDelivery's Products Attract Growing Interest
- VFC submits: Shares of BioDelivery Sciences BDSI broke above the $5 dollar barrier for the first time in a little while after a Tuesday morning press release announced that the company has received a $1.3 million grant from the Walter Reed Army Institute of Research. The grant, according to...
- External links 2009-10-07
- Remaining Grounded Through the Unethical Attacks on Cel Sci
- VFC submits: [Update below] Shares of Cel Sci Corp CVM were on the rebound during early trading on Wednesday after the effects of some unfounded attacks on the company by Adam Feuerstein and The Street.com look to have finally wore off. by VFC's Stock House
- External links 2009-10-08
- Cel Sci: Job Listings Are a Good Sign
- VFC submits: What's left to say about Cel Sci Corp. CVM? That company and its stock have received a heck of a lot of press over the past couple of weeks and I maintain my opinion that - in my opinion - the stock will pay off based on...
- External links 2009-10-08
- Continuing to Accumulate Peregrine Pharma at Current Levels
- VFC submits: On Monday Peregrine Pharmaceuticals issued a press release announcing Positive Results From the company's Phase II Bavituximab Lung Cancer Trial. A full copy of the press release is here. The PR had little, if any, influence on the stock price. I started accumulating shares of this...
- External links 2009-10-08
- A Regular Revenue Stream for BioDelivery Sciences Is Imminent
- VFC submits: BioDelivery Sciences BDSI announced in a Thursday morning press release that the company's recently-FDA-approved treatment for breakthrough pain in cancer patients, Onsolis, is ready for a commercial launch. The commercial launch of the product, according to the press release, will take place next week by the US...
- External links 2009-10-09
- Capstone Turbine Is Still a Stock to Watch
- VFC submits: Capstone Turbine CPST announced a new distributor on Tuesday when the company named PFI Energy & Ecology as their distributor for Argentina.Capstone, the maker of low-emission and 'clean' microturbine energy systems, is growing in presence around the world as investors wait for the potential to grow the...
- External links 2009-10-09
- Keryx Biopharma Investors Should Wait for More News on Trials
- VFC submits: Shares of Keryx Biopharmaceuticals KERX spiked as high as $1.46 on Thursday morning after the company announced the initiation of another Phase II study for Perifosine, this time to measure the drug's effectiveness in treating relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).The...
- External links 2009-10-09
- CEO Interview Shows Celsius Is Primed to Pop
- VFC submits: The CEO of Celsius Holdings (CSUH.OB), Steve Haley, joined a moderator from Investment Nation on Thursday evening for a live interview to discuss the latest and greatest regarding Celsius the company and Celsius the product.For those who may be new to the product, Celsius lays claim to...
- External links 2009-10-11
- BDSI Insider Selling Was a Blessing for Investors
- VFC submits: BDSI: A comment from Bluesbuff regarding the insider sales at BioDelivery Sciences BDSI earlier this year: Vinnie, by VFC's Stock House
- External links 2009-10-12
- The Worst Is Way Behind Titan Pharma
- VFC submits: [Update below] I've discussed Titan Pharmaceuticals (TTNP.PK) in great depth here over the past eight months or so, but a rundown of where I think this stock could go - based on the potential of Fanapt sales and Titan's 8-10% royalty rate - is as follows: by...
- External links 2009-10-02
- BioDelivery Sciences Requires Strong Investor Confidence
- VFC submits: Shares of BioDelivery Sciences BDSI put a halt to the stock's current downtrend on Monday, closing at $4.79 after closing last week at $4.24. Early trading on Tuesday saw the stock trading relatively flat, aside from an early morning when BDSI spiked to nearly five dollars.Monday's spike,...
- External links 2009-09-30
- Cell Therapeutics Looks Good, Antigenics Looks Better
- VFC submits: In response to a number of requests that I've received via email or comments asking for 'VFC's Take' on numerous stocks that readers have found, I'll do my best to address as many as I can, as long as everyone takes a few things into account while...
- External links 2009-09-08
- Anadys: Better Speculative Plays Out There
- VFC submits: In response to a number of requests that I've received via email or comments asking for 'VFC's Take' on numerous stocks that readers have found, I'll do my best to address as many as I can, as long as everyone takes a few things into account while...
- External links 2009-09-10
- Stock Watch: CPST, CSUH.ob
- VFC submits: CPST: Shares of Capstone Turbine broke through the $1.50 mark during early trading on Monday after two fairly significant press releases hit the wires before the trading day commenced.First, the Nasdaq OMX group announced that it will be adding five companies to the Clean Edge Green Energy...
- External links 2009-09-14
- << Previous
- page 1 of 7
- Next >>
Refining Tags
- Biotech (78 results)
- Healthcare (44 results)
- Antigenics Inc. (20 results)
- BioDelivery Sciences International Inc. (18 results)
- CEL-SCI Corp. (14 results)
- Retail (9 results)
- Media (8 results)
- EpiCept Corp. (6 results)
- Vanda Pharmaceuticals Inc. (6 results)
- Energy (5 results)
- Insmed Inc. (5 results)
- Capstone Turbine (5 results)
- US Market (4 results)
- Sirius Satellite Radio Inc. (4 results)
- Sirius (4 results)
- Materials & Industrials (4 results)
- Keryx Biopharmaceuticals Inc. (4 results)
- Marvel Entertainment Inc. (3 results)
- Capstone Turbine Corp. (3 results)
- Financial (3 results)
